Lymph Node Ratio as a Predictor for Outcome in Rectal Cancer
NCT ID: NCT05221684
Last Updated: 2022-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2020-06-09
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Significance of Lymph Node Ratio in Rectal Cancer on Overall Survival
NCT05667259
Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer
NCT01706809
Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer
NCT05572151
Fluorescence Targeted Pelvic Lymph Node Mapping
NCT03204994
Relationship Between Lymph Node Ratio and Survival Rate in Preoperative Chemoradiation Rectal Cancer Patients
NCT04096118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Selection criteria Patients of either gender aged 18 years or above who presented with rectal cancer of any stage will be included in the study. We will exclude patients with patients younger than 18 years; patients with synchronous colon cancer; synchronous liver, pulmonary or bones metastasis; or synchronous gastrointestinal cancer; or patients who were lost to follow-up.
Study endpoints The primary endpoint of the study is to assess the value of lymph node ratio (LNR) on the oncological outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lymph node harvesting
Lymph node harvesting after radical resection for rectal cancer with curative intent
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* underwent radical resection with curative intent
Exclusion Criteria
* synchronous gastrointestinal cancer
* underwent palliative resection
* presented with intestinal obstruction
* those lost to follow-up.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa shalaby, MD, MSc, PhD
Lecturer of Colorectal Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mostafa Shalaby
Role: PRINCIPAL_INVESTIGATOR
Mansoura Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura Faculty of Medicine
Al Mansurah, Dakahliya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LN ratio in rectal cancer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.